Miscarriage Risk is Doubled when Women Take Effexor
A recent study found that when women take SSRI and SNRI antidepressants, such as Effexor, during pregnancy they have a significantly higher risk of miscarriage.
A study published online in the Canadian Medical Association Journal on May 31, 2010 shows that women who take certain antidepressants during the first trimester of pregnancy have a 68 percent higher risk of miscarriage than women who do not take these drugs during pregnancy. Among the drugs that carries the highest risk is Effexor, but other drugs mentioned in the study include:
In this study, researchers used data from the Quebec Pregnancy Registry and studied pregnancies since 1997, comparing the women who miscarried in the 20th week of pregnancy to women who did not suffer early miscarriages. Results showed that when women used Effexor (venlaxafine) the risk of miscarriage nearly doubled. This study led researchers to warn that the venlaxafine (Effexor) and other antidepressants should be used with extreme caution.
Some experts believe that these miscarriages associated with Effexor may be due to malformations of essential organs. Many Effexor babies who are born suffer from heart defects, lung defects, an abnormally shaped skull (craniosynostosis), abdominal wall defects (infant omphalocele), club foot, and oral cleft birth defects such as cleft lip and cleft palate. Effexor has also been known to increase the risk of developmental delays. Since 2005, the FDA has issued warnings about the risks associated with the use of SSRI antidepressants during pregnancy.
Antidepressants may Cause Developmental Delays
Recent studies have linked significant developmental delays with the use of antidepressants during pregnancy.
A study published in Pediatrics in March 2010 linked the use of antidepressants late in pregnancy with prolonged motor developmental milestones in children at the ages of 6 and 19 months. Listed in the study were a number of antidepressants, including Effexor.
Out of 904 pregnant women in the study who reported having depression, 415 used an antidepressant medication such as Effexor. Researchers then compared certain developmental milestones between the children of mothers who used antidepressants during pregnancy and those whose mothers did not. The children exposed to antidepressants in the womb took an average of 16 days longer to sit without support, and nearly 30 days longer to walk compared to children who were not exposed to antidepressants. The study shows that boys are especially susceptible to this risk.
Contact an Effexor and Antidepressant Birth Defect Lawyer
If your child was born with a congenital birth defect or suffered developmental delays after his mother used antidepressants such as Effexor during pregnancy, you may be entitled to significant compensation. Contact a product liability attorney who practices dangerous drug litigation for a review of your claim.